Senior insider sale
President & CEO at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$18.15M
445.86K shares
What this filing means
LIAN BRIAN plans to sell 445.86K shares of VIKING THERAPEUTICS, INC. valued at approximately $18.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/20/2024ACC: 0000103623-24-000077
DirectorOfficer· President & CEO
Since Jan 2019
445.86K
Shares to sell
$18.15M
Approx. market value
216.13K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months3
NQSO
N/A
1/3/2020
99KNQSO
N/A
1/3/2020
67.13KFounder Shares
N/A
8/1/2012
50KTotal acquired216.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2020 | NQSO N/A | 99K | — |
1/3/2020 | NQSO N/A | 67.13K | — |
8/1/2012 | Founder Shares N/A | 50K | — |
| Total | 216.13K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1K
Market value
$69.9K
8/21/2024
—Completed
Units to sell
112.87K
Market value
$7.43M
8/19/2024
—Completed
Units to sell
115.86K
Market value
$6.67M
7/30/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
216.13K
Market value
$3.98M
9/20/2024
Total
Units
445.86K
Value
$18.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/21/2024 | 1K | $69.9K | — | Completed |
8/19/2024 | 112.87K | $7.43M | — | Completed |
7/30/2024 | 115.86K | $6.67M | — | Completed |
| Planned — Approximate Date | ||||
9/20/2024 | 216.13K | $3.98M | NASDAQ | Planned |
| Total | 445.86K | $18.15M | ||